Stockscreener 앱 받기
9.64
1.33%
-0.13
전일 마감가:
$9.77
열려 있는:
$9.7
하루 거래량:
143.34K
Relative Volume:
0.22
시가총액:
$442.33M
수익:
$524.73M
순이익/손실:
$31.70M
주가수익비율:
14.57
EPS:
0.6617
순현금흐름:
$22.47M
1주 성능:
-5.12%
1개월 성능:
-21.37%
6개월 성능:
-41.43%
1년 성능:
-18.72%
1일 변동 폭
$9.475
$9.7389
1주일 범위
$9.725
$10.28
52주 변동 폭
$9.475
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Compare CLB vs SLB, BKR, TS, HAL, FTI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
9.64 | 442.33M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
47.77 | 70.88B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Co
|
53.82 | 53.43B | 27.89B | 3.15B | 2.29B | 3.1363 |
TS
Tenaris Sa Adr
|
57.44 | 28.99B | 12.19B | 2.03B | 1.87B | 3.8072 |
HAL
Halliburton Co
|
32.42 | 27.01B | 22.37B | 1.61B | 1.73B | 1.9091 |
FTI
Technipfmc Plc
|
67.85 | 26.61B | 10.17B | 1.08B | 1.34B | 2.6138 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-13 | 업그레이드 | Johnson Rice | Hold → Buy |
| 2025-03-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-06-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2023-04-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-10-07 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-09-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-07-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-11-11 | 재확인 | Cowen | Market Perform |
| 2020-10-13 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-09-29 | 업그레이드 | ABN Amro | Sell → Hold |
| 2020-07-16 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-01-31 | 재확인 | Cowen | Market Perform |
| 2020-01-30 | 재개 | Johnson Rice | Buy |
| 2020-01-14 | 개시 | Bernstein | Mkt Perform |
| 2020-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-12-31 | 재확인 | Cowen | Market Perform |
| 2019-07-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | 업그레이드 | Tudor Pickering | Hold → Buy |
| 2018-12-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2018-11-01 | 업그레이드 | ABN Amro | Sell → Buy |
| 2018-10-29 | 재확인 | Cowen | Market Perform |
모두보기
Core Laboratories Inc 주식(CLB)의 최신 뉴스
Form 4 Core Laboratories NV For: 5 October - Investing.com India
Form 4 Core Laboratories NV For: 5 October By Investing.com - Investing.com Australia
Form 4 Core Laboratories NV For: 5 October By Investing.com - Investing.com Canada
Core Laboratories Inc. (CLB) Stock Forecasts - Yahoo Finance
Core Laboratories Inc. (CLB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Core Laboratories sets Oct 29 call for Q3FY26 results - scanx.trade
After the Oct. 28 close, Core Laboratories will release its results; a webcast follows next morning. - Stock Titan
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - TradingView
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - Moomoo
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - Yahoo Finance
CLB Declines 35% in the Past Six Months: How to Play the Stock? - tradingview.com
CLB Declines 35% in the Past Six Months: How to Play the Stock? - TradingView
CLB Declines 35% in the Past Six Months: How to Play the Stock? - Yahoo Finance
Top Core Laboratories (CLB) Competitors 2026 - MarketBeat
Zacks Research Cuts Earnings Estimates for Core Laboratories - MarketBeat
Zacks Research Expects Weaker Earnings for Core Laboratories - MarketBeat
Global Perforating Gun Market Entering High-Growth Phase - openPR.com
Legal & General Group Plc Buys Shares of 122,575 Core Laboratories Inc. $CLB - MarketBeat
Bank of New York Mellon Corp Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories - finance.yahoo.com
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories - Eastern Progress
Core Porosity Analyzers Market - Future Market Insights
3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges - TradingView
BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Bank of America Corp DE Has $3.77 Million Position in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories NV (CLB) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Core Laboratories NV (CLB) Key Financial Ratios – Valuation, Profitability & More - Value Research
Kwaku Temeng to Resign from Core Laboratories Board, Effective Oct 1, 2026 - TradingView
Core Laboratories (NYSE: CLB) director resigns over strategy dispute - Stock Titan
Core (CLB) Quarter in Focus: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
Gulfport Energy and Mobility Global Set to Join S&P SmallCap 600 - easternprogress.com
Core Laboratories Inc. CLB Stock Forecast & Price Target - Yahoo Finance
Q4 EPS Forecast for Core Laboratories Lifted by Analyst - MarketBeat
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value - GuruFocus
Canuc Announces New Board Member - TMX Newsfile
What is Zacks Research's Forecast for CLB FY2026 Earnings? - MarketBeat
101,648 Shares in Core Laboratories Inc. $CLB Purchased by Rice Hall James & Associates LLC - MarketBeat
3 Reasons CLB is Risky and 1 Stock to Buy Instead - Yahoo Finance
CLB Q2 2026 Earnings: EPS Beats by 25.1% as Operational Execution Drives ResultsFinancial Summary - vinanet.vn
Renaissance Technologies LLC Sells 132,797 Shares of Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (CLB) Holds Above $12.40 as Oilfield Services Sector StabilizesTriple Top - vinanet.vn
Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan
Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - MarketBeat
Core Laboratories Inc. (CLB) stock price, news, quote and history - Yahoo Finance Australia
Core Laboratories Inc. (HJ1.F) stock price, news, quote and history - Yahoo Finance UK
Reservoir Analysis Market Research Explores Growth Within A $14.7 Billion Opportunity - openPR.com
CLB Q2 2026 Earnings: EPS Beats Estimates by 25.14%, Delivering a Notable Upside SurpriseEarnings Whisper Number - vinanet.vn
Core Laboratories N.V. (CLB) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories Inc (CLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Core Laboratories Inc 주식 (CLB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Teo Sow Hang | CAO & Treasurer |
Oct 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
8,917 |
| Teo Sow Hang | CAO & Treasurer |
Aug 01 '26 |
Option Exercise |
0.00 |
440 |
0 |
8,775 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
Aug 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,764 |
| Bruno Lawrence | Chairman and CEO |
Jul 31 '26 |
Buy |
10.78 |
5,000 |
53,900 |
262,438 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,611 |
| Carnes Martha Z. | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
54,397 |
| MARTINOVICH ROBERT F | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
8,069 |
| Murray Katherine | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
29,290 |
| ANASTASIO CURT | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
23,805 |
| Klingensmith Harvey Robert | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
50,031 |
1.87%
자본화:
|
볼륨(24시간):